Literature DB >> 3956421

Circulating insulin-like growth factor I levels in newborn premature and full-term infants followed longitudinally.

J D Lineham, R M Smith, G W Dahlenburg, R A King, R R Haslam, M C Stuart, L Faull.   

Abstract

Longitudinal circulating levels of insulin-like growth factor I (IGF-I) were measured by radioimmunoassay after acid/ethanol extraction of serum or plasma in 44 appropriate-for-gestational age (AGA) premature infants, 7 small-for-gestational age (SGA) premature infants and 9 AGA full-term infants. The subjects were divided into cohorts with gestational age at birth 26-29 weeks, 30-33 weeks, 34-37 weeks and 38-42 weeks (full-term). The premature infants in this study exhibited diminished growth as compared with normal intrauterine growth. In all but the earliest premature infant cohort there was an immediate fall from the mean fetal IGF-I level, as reflected by the cord value, to a basal postnatal circulating level of IGF-I. The basal level of circulating IGF-I in premature infants was related only to gestational age. It increased slowly from 25 weeks gestation until four weeks after full-term equivalent and was independent of time of birth. Full-term infants were distinguished from early premature infants by the occurrence of a prominent postnatal surge in circulating IGF-I levels that was characterised by a significant (P less than 0.02) increase between day 1 and days 10-15. The SGA and AGA infants in the 34-37 week cohort showed similar profiles of circulating IGF-I with no significant difference in cord values between the two groups.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3956421     DOI: 10.1016/0378-3782(86)90096-4

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  22 in total

1.  Children's Hospital of Philadelphia Score to predict severe retinopathy in Indian preterm infants.

Authors:  Suraj Doshi; Saumil Desai; Ruchi Nanavati; Nandkishor Kabra; Snehal Martin
Journal:  Eye (Lond)       Date:  2019-04-08       Impact factor: 3.775

Review 2.  Retinopathy of prematurity.

Authors:  Ann Hellström; Lois E H Smith; Olaf Dammann
Journal:  Lancet       Date:  2013-06-17       Impact factor: 79.321

3.  A predictive score for retinopathy of prematurity by using clinical risk factors and serum insulin-like growth factor-1 levels.

Authors:  Yeşim Coşkun; Ceyhun Dalkan; Özge Yabaş; Özlem Ünay Demirel; Elif Samiye Bayar; Sibel Sakarya; Tuba Müftüoğlu; Dilaver Erşanlı; Nerin Bahçeciler; İpek Akman
Journal:  Int J Ophthalmol       Date:  2017-11-18       Impact factor: 1.779

4.  Development and verification of a pharmacokinetic model to optimize physiologic replacement of rhIGF-1/rhIGFBP-3 in preterm infants.

Authors:  Jou-Ku Chung; Boubou Hallberg; Ingrid Hansen-Pupp; Martin A Graham; Gerald Fetterly; Jyoti Sharma; Adina Tocoian; Nerissa C Kreher; Norman Barton; Ann Hellström; David Ley
Journal:  Pediatr Res       Date:  2016-11-21       Impact factor: 3.756

5.  POSTNATAL SERUM INSULIN-LIKE GROWTH FACTOR I AND RETINOPATHY OF PREMATURITY.

Authors:  Anne K Jensen; Gui-Shuang Ying; Jiayan Huang; Graham E Quinn; Gil Binenbaum
Journal:  Retina       Date:  2017-05       Impact factor: 4.256

6.  A physiologic reduced oxygen protocol decreases the incidence of threshold retinopathy of prematurity.

Authors:  Kenneth W Wright; David Sami; Lisa Thompson; Rangasamy Ramanathan; Roy Joseph; Sonal Farzavandi
Journal:  Trans Am Ophthalmol Soc       Date:  2006

Review 7.  The biology of retinopathy of prematurity: how knowledge of pathogenesis guides treatment.

Authors:  Lois E Smith; Anna-Lena Hard; Ann Hellström
Journal:  Clin Perinatol       Date:  2013-06       Impact factor: 3.430

Review 8.  Algorithms for the prediction of retinopathy of prematurity based on postnatal weight gain.

Authors:  Gil Binenbaum
Journal:  Clin Perinatol       Date:  2013-06       Impact factor: 3.430

Review 9.  Understanding ischemic retinopathies: emerging concepts from oxygen-induced retinopathy.

Authors:  Elsa Kermorvant-Duchemin; Przemyslaw Sapieha; Mirna Sirinyan; Martin Beauchamp; Daniella Checchin; Pierre Hardy; Florian Sennlaub; Pierre Lachapelle; Sylvain Chemtob
Journal:  Doc Ophthalmol       Date:  2009-10-31       Impact factor: 2.379

10.  Elevated levels of IL-6 and IGFBP-1 predict low serum IGF-1 levels during continuous infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants.

Authors:  Susanna Klevebro; Gunnel Hellgren; Ingrid Hansen-Pupp; Dirk Wackernagel; Boubou Hallberg; Jan Borg; Aldina Pivodic; Lois Smith; David Ley; Ann Hellström
Journal:  Growth Horm IGF Res       Date:  2019-11-09       Impact factor: 2.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.